What we do > Human Health

How mRNA works for Human Health

IN THE PIPELINE

Messenger RNA for vaccines and therapies

Messenger RNA’s features make it broadly valuable for human health. It is well known that mRNA is being used to make effective Covid-19 vaccines that have been developed quickly—critical for pandemic response. GreenLight is working on multiple vaccines and therapeutic uses of mRNA.

RNA IN ACTION

We are developing therapeutics for critical diseases facing patients worldwide.

IN THE PIPELINE

Vaccines for infectious diseases

Our Covid-19 mRNA vaccine product is in development. We envision a global network of modular manufacturing units that would allow us to commercially produce more than one billion vaccine doses annually, meeting local demand through local production.

Read more

IN THE PIPELINE

Gene therapies

Many genetic diseases have no permanent cure. For example, current treatments for sickle cell disease focus on managing pain and other effects, such as anemia. These treatment regimens are costly, invasive, and impractical. Our RNA-based gene therapy is capable of delivering a healthy copy of the gene to stem cells.

Read more

IN THE PIPELINE

Monoclonal antibodies

We are currently working on early stage development of monoclonal antibodies as a modality.

close up shot of a woman with a clip board
someone writing mrna on a test tube

Why it’s so powerful

  • Multiple opportunities

    Messenger RNA can be used for both vaccines and therapies.

  • Fast development

    Simple changes to the messenger RNA molecule allow us to make new products quickly.

  • Versatile design

    Simple changes to the messenger RNA molecule allow us to make new products quickly.

a close up of some test tubes in an orange stand
two women work in the Woburn lab

BECOME A PARTNER

We won’t succeed alone

We work with some of the world’s leading universities, companies, and scientists

Learn more

News and insights

The latest on GreenLight’s work and partnerships, and what the world has been saying about us.

All news
  • ENVI and GreenLight Biosciences File Definitive Proxy Statement/Prospectus; February 1st, 2022, Meeting to Approve Proposed Business Combination

    01.14.22


    ENVI and GreenLight Biosciences File Definitive Proxy Statement/Prospectus; February 1st, 2022, Meeting to Approve Proposed Business Combination
    GO!
  • GreenLight Biosciences expands RTP footprint for the next generation of agricultural products

    01.07.22


    GreenLight Biosciences expands RTP footprint for the next generation of agricultural products
    GO!
  • GreenLight and ENVI announce a recent financing to support their pending business combination

    01.05.22


    GreenLight and ENVI announce a recent financing to support their pending business combination
    GO!
  • GreenLight research recognized in four top tier peer-reviewed papers in 2021

    12.20.21


    GreenLight research recognized in four top tier peer-reviewed papers in 2021
    GO!
  • The Boston Globe names GreenLight Biosciences a top place to work for 2021

    12.13.21


    The Boston Globe names GreenLight Biosciences a top place to work for 2021
    GO!
  • Unherd: Should Big Pharma be destroyed?

    12.04.21


    Unherd: Should Big Pharma be destroyed?
    GO!